Summit Global Investments’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Summit Global Investments's LMAT Position: Q3 2026 in Review
Summit Global Investments sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 3,803 shares — an estimated $365K sold.
Summit Global Investments first reported a position in LMAT in Q2 2017 and held it in 15 quarters. The position peaked at $1.1M in Q4 2023. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Summit Global Investments reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
- Summit Global Investments sold 3,803 LeMaitre Vascular shares in Q3 2026, an estimated $365K.
- Summit Global Investments first reported a position in LeMaitre Vascular in Q2 2017 and held it in 15 quarters.
- Summit Global Investments's LeMaitre Vascular position peaked at $1.1M in Q4 2023.
- 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Summit Global Investments's 13F filing for Q3 2026, filed 28 Oct 2026.